Pala-Kara Z - Search Results

1

Pharmacokinetics of talinolol is modified by barnidipine: implication of P-glycoprotein modulation.

Ozturk N, Ozturk D, Pala-Kara Z, Okyar A. Ozturk N, et al. Among authors: pala kara z. Pharmazie. 2017 Jan 10;72(1):29-34. doi: 10.1691/ph.2017.6786. Pharmazie. 2017. PMID: 29441894

2

The effect of terpenes on percutaneous absorption of tiaprofenic acid gel.

Okyar A, Nuriyev M, Yildiz A, Pala-Kara Z, Ozturk N, Kaptan E. Okyar A, et al. Among authors: pala kara z. Arch Pharm Res. 2010 Nov;33(11):1781-8. doi: 10.1007/s12272-010-1110-8. Epub 2010 Nov 30. Arch Pharm Res. 2010. PMID: 21116781

3

Carbon tetrachloride-induced kidney damage and protective effect of Amaranthus lividus L. in rats.

Yilmaz-Ozden T, Can A, Karatug A, Pala-Kara Z, Okyar A, Bolkent S. Yilmaz-Ozden T, et al. Among authors: pala kara z. Toxicol Ind Health. 2016 Jun;32(6):1143-52. doi: 10.1177/0748233714555390. Epub 2014 Nov 20. Toxicol Ind Health. 2016. PMID: 25415872

4

Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study.

Pilancı KN, Saglam S, Okyar A, Yucel S, Pala-Kara Z, Ordu C, Namal E, Ciftci R, Iner-Koksal U, Kaytan-Saglam E. Pilancı KN, et al. Among authors: pala kara z. Cancer Chemother Pharmacol. 2016 Jul;78(1):143-50. doi: 10.1007/s00280-016-3067-x. Epub 2016 Jun 6. Cancer Chemother Pharmacol. 2016. PMID: 27270460 Clinical Trial.

5

The immune system as a chronotoxicity target of the anticancer mTOR inhibitor everolimus.

Ozturk N, Ozturk D, Pala-Kara Z, Kaptan E, Sancar-Bas S, Ozsoy N, Cinar S, Deniz G, Li XM, Giacchetti S, Lévi F, Okyar A. Ozturk N, et al. Among authors: pala kara z. Chronobiol Int. 2018 May;35(5):705-718. doi: 10.1080/07420528.2018.1432632. Epub 2018 Feb 5. Chronobiol Int. 2018. PMID: 29400578

6

The effects of P-glycoprotein inhibitor zosuquidar on the sex and time-dependent pharmacokinetics of parenterally administered talinolol in mice.

Pala Kara Z, Ozturk Civelek D, Ozturk N, Okyar A. Pala Kara Z, et al. Eur J Pharm Sci. 2021 Jan 1;156:105589. doi: 10.1016/j.ejps.2020.105589. Epub 2020 Oct 10. Eur J Pharm Sci. 2021. PMID: 33049306

7

Dosing-time dependent testicular toxicity of everolimus in mice.

Ozturk N, Ozturk Civelek D, Sancar S, Kaptan E, Pala Kara Z, Okyar A. Ozturk N, et al. Among authors: pala kara z. Eur J Pharm Sci. 2021 Oct 1;165:105926. doi: 10.1016/j.ejps.2021.105926. Epub 2021 Jul 7. Eur J Pharm Sci. 2021. PMID: 34242751

8

Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice.

Akyel YK, Ozturk Civelek D, Ozturk Seyhan N, Gul S, Gazioglu I, Pala Kara Z, Lévi F, Kavakli IH, Okyar A. Akyel YK, et al. Among authors: pala kara z. J Biol Rhythms. 2023 Apr;38(2):171-184. doi: 10.1177/07487304221148779. Epub 2023 Feb 10. J Biol Rhythms. 2023. PMID: 36762608 Free PMC article.

9

The role of the circadian timing system on drug metabolism and detoxification: an update.

Okyar A, Ozturk Civelek D, Akyel YK, Surme S, Pala Kara Z, Kavakli IH. Okyar A, et al. Among authors: pala kara z. Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):503-517. doi: 10.1080/17425255.2024.2356167. Epub 2024 May 20. Expert Opin Drug Metab Toxicol. 2024. PMID: 38753451 Review.

10

Dosing-time, feeding, and sex-dependent variations of everolimus pharmacokinetics in mice.

Ozturk Civelek D, Ozturk Seyhan N, Akyel YK, Gazioglu I, Pala Kara Z, Orman MN, Okyar A. Ozturk Civelek D, et al. Among authors: pala kara z. Fundam Clin Pharmacol. 2024 Oct;38(5):883-896. doi: 10.1111/fcp.13003. Epub 2024 Mar 18. Fundam Clin Pharmacol. 2024. PMID: 38500383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters